Rhianna Parsons

AMADEUS is now open at 19 UK transplant centres. To date, 197 patients have been screened and 163 patients have been randomised to receive either oral azacitidine or placebo, meaning as of September 2021 over half of the required 324 patients have been recruited to AMADEUS.

IMPACT, the UK’s first ever clinical trials partnership dedicated to improving the outcomes for blood cancer stem cell transplant patients, has appointed Professor Ronjon Chakraverty as Medical Director.

The IMPACT Clinical Trials Network is excited to collaborate with Dr Giovanna Lucchini at Great Ormond Street Hospital (GOSH) on a study of COVID19 infection in allogenic stem cell recipients